breast cancer

News

AZ, Daiichi Sankyo cue up TROP2 drug filing in breast cancer

Armed with the first phase 3 data for their TROP2-targeting antibody-drug conjugate (ADC) datopotamab deruxtecan as a second-line treatment for breast cancer, AstraZeneca

News

Menarini brings oral SERD to Europe with Orserdu okay

Menarini has secured EU approval for Orserdu, the first in a new class of oral selective oestrogen receptor degrader (SERD) drugs and the first innovation in endocrine the

News

Seagen posts breast cancer win ahead of Pfizer takeover

The combination of two HER2-targeting drugs – Seagen's oral Tukysa and Roche's intravenous antibody-drug conjugate (ADC) Kadcyla – has shown a benefit over Kadcyla alone a

News

AI shows its value in mammography screening

A study has shown that artificial intelligence can be safely used to support mammography to spot breast cancers and may spot more tumours than the current standard approac

News

Wales expands NHS use of AI for cancer diagnosis

The devolved Welsh Government plans to expand the use of an artificial intelligence-powered tool used to spot cancer in biopsy samples, after seeing a 13% increase in pros

Oncology

Oncotype DX: Breast cancer, genomics, and rethinking the onc...

EXACT Sciences presented ten new pieces of data at the San Antonio Breast Cancer Symposium (SABCS) back in late 2022, highlighting the impact of its precision oncology portfolio on breast c

AZ, Daiichi Sankyo cue up TROP2 drug filing in breast cancer

Menarini brings oral SERD to Europe with Orserdu okay

Seagen posts breast cancer win ahead of Pfizer takeover

AI shows its value in mammography screening

Wales expands NHS use of AI for cancer diagnosis

Oncotype DX: Breast cancer, genomics, and rethinking the onc...

Praxis soars on rare childhood epilepsy trial data

How to meet your physicians where they are online

breast cancer

Editor's Picks